Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.05 USD | -0.77% | +2.50% | +38.92% |
04-30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
04-29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.92% | 579M | |
-3.05% | 90.45B | |
+3.95% | 41.45B | |
-10.84% | 33.57B | |
+60.58% | 25.73B | |
-20.29% | 14.73B | |
-8.79% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.24% | 8.79B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Stephens Adjusts Avid Bioservices Price Target to $20 From $24, Maintains Overweight Rating